PD-L1+ Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-ү and IL-21 Production
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26072998 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mustafa Talib und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Eötvös Loránd University, 1053 Budapest, Hungary. Hauptthemen laut MEDLINE: B-Lymphocytes, Regulatory, Arthritis, Rheumatoid, Interleukins, B7-H1 Antigen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development, and Innovation Office.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease. The pathomechanism of RA depends on both B and T cells. Regulatory B cells (Breg) have been shown to suppress T-cell immune responses and play a key role in modulating autoimmune processes. We aimed to investigate the possibility of utilizing PD-L1+ Breg cells in downregulating the Th cells’ immune response in healthy individuals and RA patients. We hypothesized that the PD-1/PD-1L interaction plays a key role in this process, which may be defective in autoimmune diseases. We separated T and B cells from the peripheral blood of healthy volunteers and RA patients by magnetic cell sorting, and Th cells and Treg cells were isolated by fluorescence-activated cell sorting. The cytokine production by CD4+ Th cells was detected by intracellular flow cytometry. CpG and CD40L stimulations were applied to induce PD-L1hi expressing Breg cells. We found that the frequency of PD-L1hi cells is significantly lower in all B-cell subsets in RA compared to healthy controls. Functional analysis of induced PD-L1+ Breg cells in coculture with activated autologous Th cells has shown that healthy control samples containing higher levels of PD-L1hi Breg cells significantly inhibit IFN-ү and IL-21 production by Th cells. In contrast, RA patients’ samples with lower levels of PD-L1hi Breg cells failed to do so. Since the expression of PD-L1 on B cells can be modulated in vitro to induce Breg cell suppressive capacity, these data may provide new perspectives for future therapy for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Eötvös Loránd University, 1053 Budapest, Hungary.
- Rheumatology-Rehabilitation Department, Buda Hospital of the Hospitaller Order of Saint John of God, 1027 Budapest, Hungary.
- Department of Rheumatology and Immunology, Semmelweis University, 1023 Budapest, Hungary.
- Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Hungary.
ORCID-Profile: Mustafa Talib, Balázs Gyebrovszki, Anna Fodor, Kata Balog Virág
Förderung
- National Research, Development, and Innovation Office
Zitieren
APA
Talib, M., Gyebrovszki, B., Fodor, A., Mészáros, A., Balog Virág, K., Barta, L. G., Rojkovich, B., Nagy, G., & Sármay, G. (2025). PD-L1+ Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-ү and IL-21 Production. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072998
Vancouver
Talib M, Gyebrovszki B, Fodor A, Mészáros A, Balog Virág K, Barta LG, et al. PD-L1+ Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-ү and IL-21 Production. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072998
BibTeX
@article{Talib2025,
author = {Talib, Mustafa and Gyebrovszki, Balázs and Fodor, Anna and Mészáros, Anna and Balog Virág, Kata and Barta, Leila Gloria and Rojkovich, Bernadette and Nagy, György and Sármay, Gabriella},
title = {PD-L1+ Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-ү and IL-21 Production},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26072998}
}
EUVIMED